MedPath

Prehabilitation in Oncological Patients Undergoing Major Gastrointestinal Surgery (PROGRESS)

Not Applicable
Recruiting
Conditions
Major Surgery
Oncological Patients
Interventions
Behavioral: Multimodal prehabilitation Program
Registration Number
NCT06404489
Lead Sponsor
Università Vita-Salute San Raffaele
Brief Summary

The importance of postoperative rehabilitation on physical performance and recovery is well-recognized. However, the preoperative period constitutes a unique opportunity to address comorbidities and modifiable risk factors, improve functional capacity and address deficiencies in physiologic reserve, which might otherwise preclude surgery or significantly impede recovery.

Therefore, the aim of this study is to evaluate the efficacy of a multimodal program of prehabilitation in patients undergoing major oncological gastrointestinal surgery. The hypothesis is that severe post-operative complications within 30 days will be reduced in the treatment group compared to the control group.

Detailed Description

This is a 2-arm randomized multicentric controlled trial to test the efficacy of a personalized, multidisciplinary, preoperative conditioning program to reduce severe complications and facilitate recovery in patients undergoing major oncological gastrointestinal surgery.

400 patients will be randomized (ratio 1:1) and allocated either to the intervention group (Prehabilitation), or to the control group (which will be treated according to usual standard of care within Enhanced Recovery After Surgery (ERAS) pathways).

Multimodal prehabilitation is a preoperative intervention which includes exercise training, nutritional therapy and anxiety reducing techniques, aimed at preventing or attenuating surgery-driven functional decline.

The primary objective is to evaluate the effect of a multimodal program of prehabilitation on postoperative severe complications.

Secondary outcomes include time to functional recovery, length of hospital stay, complication severity, proportion of patients returning to preoperative functional walking capacity and self-reported activity status and generic health related quality of life at 30 days after surgery.

Included patients will be randomized and allocated either to the intervention group, which will receive 4 weeks of prehabilitation, or to the control group, which will receive no prehabilitation. All patients will be reassessed the day before surgery, 30 days and 3 months after surgery.

Patients enrolled in treatment group will not receive any additional medication but only a multimodal program to optimize their preoperative functional capacity.

Within 30 days prior to scheduled surgery, participants of both groups will undergo a specialized multidisciplinary assessment with a physician, a certified physiotherapist, registered dietitian and psychology trained personnel. All tests will be performed following international guidelines and standardized verbal instructions. A tailored intervention will be prescribed if specific physical, nutritional or psychological impairments will be identified during the assessment phase. Based on the data obtained during the multimodal assessment, different domains and levels of care will be prescribed, focusing on exercise training, and/or nutrition optimization, and/or distress-coping techniques. Different combinations of three domains will be utilized to maximize their synergistic anabolic effect.

Statistical analysis will be performed according to study sites, type of surgery (esophageal, gastric, colonic, rectal) and neoadjuvant treatment.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • All adult patients (age > 18 years) scheduled for elective gastrointestinal surgery for cancer.
  • Signed informed consent
Exclusion Criteria

Co-morbid medical, physical, and mental conditions interfering with the ability to complete study procedures, such as:

  • acute or unstable cardio-respiratory conditions (e.g., unstable angina or symptomatic severe aortic stenosis)
  • severe/end-stage organ diseases (e.g., cardiac failure NYHA functional classes III-IV, COPD FEV1 <50% pred, end-stage kidney or liver disease);
  • American Society of Anesthesiologists (ASA) physical status classes 4-5.
  • disabling orthopedic and neuromuscular disease.
  • psychosis, dementia;
  • symptomatic anemia.
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PrehabilitationMultimodal prehabilitation ProgramPrehabilitation arm group will receive preoperative intervention which includes exercise training, nutritional therapy and anxiety reducing techniques, aimed at preventing or attenuating surgery-driven functional decline.
Primary Outcome Measures
NameTimeMethod
Postoperative complicationsEvaluation of severe post-operative complications within 30 days

Reduction of incidence of postoperative complications.

Secondary Outcome Measures
NameTimeMethod
Proportion of patients returning to preoperative functional walking capacity30 days after surgery, 90 days follow up after surgery

Improving return to basal functional preoperative capacity

Lenght of hospital stay30 days after surgery

Reduction of lenght of hospital stay in treatment group

Trial Locations

Locations (2)

Azienda Ospedaliera Universitaria

🇮🇹

Cagliari, Sardegna, Italy

IRCCS San Raffaele Scientific Institute

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath